Amyris
Emeryville
About Amyris
Amyris Biotechnologies creates renewable products that focus on fuels and chemicals that provide no-compromise sustainable alternatives to a broad range of petroleum-sourced products. It uses an industrial synthetic biology platform that applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. Its technology creates products that support biopharmaceutical drug discovery and production, from cosmetic emollients and fragrances to fuels, solvents, lubricants, and nutraceuticals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $1.9B
- Funding stage: IPO
- Last round: Grant (Oct 2024)
- Ticker: nasdaq:AMRS
- Website: amyris.com
- Phone: 510-450-0761
Industries & Categories
Biotechnology, Chemical, CleanTech, Renewable Energy
Social Profiles
Canonical: https://fsome.com/organization/amyris-52987 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.